The niacin challenge test in schizophrenia: past, present and future.

[1]  R. Andersson,et al.  Studies on the mechanism of flush induced by nicotinic acid. , 2009, Acta pharmacologica et toxicologica.

[2]  P. Williamson,et al.  An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. , 1995, Archives of general psychiatry.

[3]  D. Horrobin,et al.  A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases , 1994, Schizophrenia Research.

[4]  C. Hudson,et al.  CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia , 1993, Synapse.

[5]  M. Keshavan,et al.  Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. , 1991, Archives of general psychiatry.

[6]  J. Rybakowski,et al.  Niacin test in schizophrenia and affective illness , 1991, Biological Psychiatry.

[7]  P. Kinnunen,et al.  Increased serum phospholipase A2 activity in schizophrenia: a replication study. , 1990, Biological psychiatry.

[8]  J. Morrow,et al.  Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. , 1989, Prostaglandins.

[9]  Jeffrey K. Yao,et al.  Polyunsaturated Fatty Acids, Prostaglandins, and Schizophrenia , 1989, Annals of the New York Academy of Sciences.

[10]  P. Kinnunen,et al.  Increased plasma phospholipase-A2 activity in schizophrenic patients: Reduction after neuroleptic therapy , 1987, Biological Psychiatry.

[11]  J. Rotrosen,et al.  Niacin-induced flush as a measure of prostaglandin activity in alcoholics and schizophrenics , 1986, Biological Psychiatry.

[12]  A. Douglass,et al.  Niacin skin flush is not diagnostic of schizophrenia , 1986, Biological Psychiatry.

[13]  J. Wilkin,et al.  Chlorpropamide-alcohol flushing, malar thermal circulation index, and baseline malar temperature. , 1982, Metabolism: clinical and experimental.

[14]  R. Kapp,et al.  Aspirin blocks nicotinic acid–induced flushing , 1982, Clinical pharmacology and therapeutics.